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Hematopoietic stem cells (HSCs) are considered a
heterogeneous cell population. To further resolve
the HSC compartment, we characterized a retinoic
acid (RA) reporter mouse line. Sub-fractionation of
the HSC compartment in RA-CFP reporter mice
demonstrated that RA-CFP-dim HSCs were largely
non-proliferative and displayed superior engraft-
ment potential in comparison with RA-CFP-bright
HSCs. Gene expression analysis demonstrated
higher expression of RA-target genes in RA-CFP-
dim HSCs, in contrast to the RA-CFP reporter
expression, but both RA-CFP-dim and RA-CFP-
bright HSCs responded efficiently to RA in vitro. Sin-
gle-cell RNA sequencing (RNA-seq) of >1,200 HSCs
showed that differences in cell cycle activity consti-
tuted the main driver of transcriptional heterogeneity
in HSCs. Moreover, further analysis of the single-cell
RNA-seq data revealed that stochastic low-level
expression of distinct lineage-affiliated transcrip-
tional programs is a common feature of HSCs.
Collectively, this work demonstrates the utility of
the RA-CFP reporter line as a tool for the isolation
of superior HSCs.
INTRODUCTION
The bone marrow (BM) is one of the most proliferative tissues
found in the body, with billions of cells produced every day to
replace damaged, exhausted, and dead cells. This massive pro-
liferative expansion is undertaken mainly by hematopoietic pro-
genitor cells (Passegue´ et al., 2005). Historically, it has been
argued that the hematopoietic stem cells (HSCs) are the critical
cells responsible for maintaining the hematopoietic system. This
is based on the fact that these are the only cells which show long-766 Cell Reports 24, 766–780, July 17, 2018 ª 2018 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://term engraftment in in vivo transplantation assays (Dykstra et al.,
2007). However, recent studies based on lineage-tracing ap-
proaches have indicated a minor role for HSCs during steady-
state hematopoiesis and instead implicated multipotent progen-
itors as the major source of mature cells (Busch et al., 2015; Sun
et al., 2014). This notion was recently challenged, suggesting
that HSCs are indeed the main contributor to hematopoietic
output even in steady state (Sawai et al., 2016).
Label retention studies have shown that a subset of HSCs is
highly quiescent and likely proliferate only four or five times dur-
ing the lifespan of a mouse (Bernitz et al., 2016; Wilson et al.,
2008). Thus, it has been hypothesized that the proliferative status
of HSCs is important for their functional capacity and that prolif-
erating HSC subsets display diminished reconstitution potential
in transplantation experiments (Bowie et al., 2006; Nygren et al.,
2006). It has even been suggested that when HSCs exit
dormancy and undergo cell division, they are not able to return
to full dormancy and are therefore destined for elimination (Qiu
et al., 2014).
In addition to showing heterogeneity in terms of cell cycle
status, numerous publications have addressed the functional
heterogeneity of HSCs in relation to their lineage bias. For
instance, using single-cell transplantation assays, the existence
of lymphoid-deficient a-HSCs (responsible for producing cells of
mainly the myeloid lineage) and balanced b-HSCs (having equal
output of myeloid and lymphoid cells) has been demonstrated
(Dykstra et al., 2007). It was hypothesized that the a-HSCs
constituted the most immature HSC population because these
could give rise to b-HSCs in secondary transplants, whereas
b-HSCs did not give rise to a-HSCs. Recently, in a study using
a transgenic murine model with GFP inserted into the Vwf locus,
evidence was presented suggesting that a platelet-biased HSC
population reside at the apex of the hematopoietic system and
is able to give rise to more myeloid-biased HSCs, possibly
resembling the previously described lymphoid-deficient a-HSC
population (Sanjuan-Pla et al., 2013).
The issue of transcriptional lineage priming was first investi-
gated almost 20 years ago in a primitive cell line retaining thecreativecommons.org/licenses/by-nc-nd/4.0/).
capability of multilineage differentiation (Hu et al., 1997). Using
single-cell RT-qPCR, the authors demonstrated the co-expres-
sion of the erythroid globin gene and the granulocytic gene en-
coding myeloperoxidase, arguing for low-level expression of
distinct lineage genes prior to definite lineage commitment.
Recently, single-cell RNA sequencing (scRNA-seq) has
emerged as a powerful tool to dissect subpopulations within
tissues (Paul et al., 2015). Although this technique has been
applied to HSCs, spurious expression of distinct lineage
markers has not been reported in HSCs. Instead, evidence
for the existence of discrete clusters with predominant expres-
sion of specific lineage genes has been presented (Tsang et al.,
2015). In this early work, the main driver of gene expression
variance in both young and aged HSCs is cell cycle-associated
genes (Kowalczyk et al., 2015). Other than cell cycle, it has not
been possible to dissect further the HSC population into
discrete subsets. This is despite the fact that not all HSCs
are able to give rise to progeny when transplanted as single
cells using stringent gating strategies and that transplantation
assays do show lineage bias of individually transplanted
HSCs (Dykstra et al., 2007).
These previous studies emphasize the importance of main-
taining HSC quiescence and reveal a significant heterogeneity
within the HSC compartment (at least with respect to cycling
status). Several factors have been shown to be essential for
HSC quiescence, and numerous studies have highlighted
the HSC niche as an important player in maintaining the quies-
cent nature of long-term HSCs (LT-HSCs) (Morrison and
Scadden, 2014). Multiple extracellular signals exert their effect
on cell function by regulating gene transcription. One such
pathway is the RA signaling pathway, which has been re-
ported to act both in paracrine and autocrine manners (Cun-
ningham and Duester, 2015). Within the hematopoietic
system, RA signaling through RARA is best known for its dif-
ferentiation-inducing effects on myeloid progenitors (Purton
et al., 1999). For murine HSCs, it has been suggested that
RA enhances self-renewal via signaling through RARG, as
RA treatment of murine hematopoietic progenitors increases
the repopulation ability of these cells and limits culture-
induced differentiation (Purton et al., 2000, 2006). Recently,
RA signaling was also shown to be important for HSC
dormancy (Cabezas-Wallscheid et al., 2017). However,
studies using HSPCs from either cord blood or adult human
BM suggest an opposite role of RA signaling in the human
system (Chute et al., 2006). Whether these discrepancies
highlight an actual difference between the murine and the hu-
man system, or whether they are related to the experimental
setup, is yet to be determined.
In the present study, we explored the possibility of using an
RA-CFP reporter mouse line to elucidate HSC heterogeneity
and efficiently isolate HSC subpopulations.
RESULTS
Robust Retinoic Acid Reporter Expression Marks
Specific Hematopoietic Subsets
We set out to explore whether we could resolve HSC hetero-
geneity using murine reporter models for the bone morpho-genic protein (BMP), wingless-type MMTV integration site fam-
ily member (Wnt), and retinoic acid (RA) signaling pathways.
These models were generated previously by replacing portions
of the Rosa26 promoter with pathway-specific response ele-
ments inserted upstream of a cerulean fluorescent protein
(CFP) cDNA. Work in embryonic stem cells has shown these
reporters to be highly sensitive and specific for their respective
ligands (Serup et al., 2012). Within the murine BM we only de-
tected robust reporter expression in the DR5-TA-RA-CFP
model reporting on RA signaling (hereinafter referred to as
RA-CFP) (Figures 1A and 1B). Across the hematopoietic sys-
tem, we detected variable RA-CFP expression patterns, with
the HSC compartment (defined as LSK, CD150+, CD48) dis-
playing a relatively narrow intermediate level of expression
(Figure 1B). When analyzing the hematopoietic progenitor
compartments in further detail, we observed the highest re-
porter expression in granulocytic-macrophage progenitors
(GMPs), in line with RA promoting the differentiation of myeloid
progenitors (Purton et al., 1999) (Figures 1C and S1A). Interest-
ingly, we also observed high reporter levels in erythroid
progenitors (pre-CFU-Es, CFU-Es, and MkP), suggesting that
in addition to its previously reported cell-extrinsic role during
erythropoiesis, RA signaling may also regulate this process
via cell-intrinsic mechanisms (Dewamitta et al., 2014).
In mature populations, both Ter119+ erythroid and CD8+
T-lymphoid cells separated clearly into RA-CFP-positive and
RA-CFP-negative populations (Figures S1B and S1C). This
suggests a potential role for RA signaling in different T cell
and erythroid subsets.
To confirm the RA sensitivity of our reporter model in the he-
matopoietic system, we sorted cKit+ cells with low and narrow
RA-CFP expression and placed them in culture with RA in the
presence and absence of the pan-RA receptor inverse agonist
BMS493. RA rapidly induced CFPmRNA and protein expression
in a dose-dependentmanner (Figures 1D, S1D, and S1E). This in-
duction was blocked by addition of BMS493, demonstrating that
CFP expression is indeed responsive to RA signaling. Addition of
BMS493 alone did not lower the reporter signal compared with
DMSO, arguing against ongoing reporter activity in this setting
(Figure S1F).
In summary, we identified distinct expression of RA-CFP
across different hematopoietic populations, with HSCs showing
a tight intermediate expression. Additionally, RA-CFP levels in
cultured hematopoietic progenitor cells responded to RA addi-
tion in a dose-dependent manner.
RA-CFP Levels Predict HSC Engraftment
In order to evaluate whether there was a functional difference in
HSCs with varying CFP levels, we carried out transplantation
assays and monitored recipients for 16 weeks. HSCs were
isolated on the basis of their CFP fluorescence into two sub-
populations: RA-CFP dim (lowest 20% CFP expression) and
RA-CFP bright (highest 20% CFP expression). One hundred
HSCs (RA-CFP dim, RA-CFP bright, or unfractionated; all
CD45.2) were subsequently transplanted along with 400,000
CD45.1 whole BM (wBM) cells into lethally irradiated recipient
mice (CD45.1) (Figure 2A). We observed an inverse correla-
tion between the RA-CFP fluorescence in HSCs and theirCell Reports 24, 766–780, July 17, 2018 767
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Figure 1. The DR5-TA-CFP Reporter Line Facilitates the Isolation of HSC Subpopulations
(A) CFP expression in LSK cells derived from wild-type (WT) (orange), DR5-TA-CFP (RA, red), SuTOP-TA-CFP (Wnt, blue), and IBRE4-TA-CFP (BMP, violet)
reporter lines. N = 3.
(B) HSC gating strategy and RA-CFP levels in immature hematopoietic cells from the RA-CFP reporter line.
(C) RA-CFP levels in various BM progenitors from the RA-CFP reporter line. For gating strategy, see Figure S1. Abbreviations: preMegE, pre-megakaryocyte/
erythroid progenitor; MkP, megakaryocytic progenitor; preGM, pre-granulocyte/macrophage; GMP, granulocyte/macrophage progenitors; CLP, common
lymphoid progenitor; CFU-E, colony-forming unit erythroid; Pre-CFU-E, pre-colony-forming unit erythroid. N = 5.
(D) Response to RA stimulation in cKit+ cells from the RA-CFP reporter line. Cells were seeded in serum-free media with varying amounts of RA or RA + BMS493
(RA inverse agonist). Aliquots were analyzed for CFP protein (flow cytometry) or mRNA (qRT-PCR). N = 3 (three mice per replicate, three replicates).
Error bars indicate SD.engraftment ability, with RA-CFP-dim HSCs contributing
approximately twice as much as RA-CFP-bright HSCs to pe-
ripheral blood (Figures 2B and 2C). Additionally, we observed
a minor difference in lineage output, with RA-CFP-dim HSCs
producing significantly more B cells compared with myeloid
cells and vice versa for RA-CFP-bright HSCs, although this
effect leveled out over time (Figures 3D–3F). The superior
ability of RA-CFP-dim HSCs for hematopoietic engraftment
was also observed in transplantation experiments involving
HSCs derived from 14-month-old animals (Figure S2).
Taken together, low RA-CFP levels identify a subpopulation of
HSCs displaying superior engraftment capability and a modest
increase in B cell potential.768 Cell Reports 24, 766–780, July 17, 2018Transcriptome Analysis of HSCs Displaying Differential
Levels of Reporter Activity
To identify transcriptional changes underlying the functional dif-
ferences between the RA-CFP-dim and RA-CFP-bright HSC
populations, we next performed RNA sequencing (RNA-seq)
and identified a total of 318 differentially expressed genes (log2
fold change > 1, p < 0.05; Figure 3A; Table S1).
Among these, a range of cell cycle-related genes, including
Aurka, Aurkab, Cdk1, and Pcna, were markedly upregulated
in the RA-CFP-bright HSCs. Consistently, gene set enrichment
analysis (GSEA) identified a variety of cell cycle signatures to
be enriched in this population (Figure 3B; Table S2), raising
the possibility that RA-CFP reporter activity may be used to
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Figure 2. RA-CFP Levels Predict HSC Engraftment
(A) Gating strategy for CFP expression in LSK, CD48, and CD150+ HSCs.
(B) Donor contribution in peripheral blood isolated from recipient mice transplanted with 100 HSCs (CD45.2), separated on the basis of CFP levels, and 400,000
wBM cells (CD45.1). Multiple comparisons were performed using one-way ANOVA. N = 8.
(C) As in (B) but showing the donor contribution in peripheral blood in individual and groups of mice over the time course of the experiment. Multiple comparisons
were performed using two-way ANOVA. Only RA-CFP dim versus RFA-CFP bright was tested.
(D–F) Lineage contribution to peripheral blood of the three groups of donor cells: B220+ (D), Mac1+ (E), and CD4/D8+ (F).
Error bars indicate SD (B) or SEM (A and C–F).distinguish between HSC populations with different prolifera-
tive properties. Consistently, cell cycle analysis demonstrated
that the RA-CFP-dim HSC population was largely quiescent,
whereas RA-CFP-bright HSCs displayed a larger proportion
of actively cycling cells (Figures 3C and 3D). Further evidencefor their quiescent nature comes from measurements of overall
protein synthesis rates demonstrating that RA-CFP-dim HSCs
are significant less metabolically active (Figure S3A). Interest-
ingly, we also found that RA-CFP expression could be used
to subdivide downstream progenitors such as short-termCell Reports 24, 766–780, July 17, 2018 769
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HSCs (ST-HSCs) and MPP2 to MPP4 into proliferating and
non-proliferating subsets (Figure S3D). We also find that cyto-
kine-mediated cell cycle entry of HSCs in vitro was associated
with increased RA-CFP expression, which could be further
enhanced by addition of RA (Figure S3E). Collectively, these
findings demonstrate that RA-CFP expression identifies prolif-
erating subsets within the HSC and multipotent progenitor
(MPP) compartments.
GSEA also identified that the expression of a number of signa-
tures related to interferon signaling were enriched in RA-CFP-
dim cells (Figure 3B; Table S2). Although in vivo stimulation
with both interferon-a and interferon-g has been shown to acti-
vate HSCs (Baldridge et al., 2010; Essers et al., 2009), several
of the interferon-regulatory genes have been implicated in the
negative regulation of cell cycle (such as Ifitm1, Irf5, and Irf6;
Bailey et al., 2008; Barnes et al., 2003; Yang et al., 2007) (Table
S3). Consistent with the notion that some interferon-signaling
genes may play a role in HSC quiescence, Irgm2 and Ifitm1,
which are both upregulated in RA-CFP-dim HSCs, were previ-
ously found by mass spectrometry to be specifically expressed
in HSCs comparedwithMPPs (Cabezas-Wallscheid et al., 2014).
In a recent study, scRNA-seq was used to identify transcrip-
tional characteristics of HSCs isolated from a variety of protocols
with the goal of capturing the essence of the HSC transcriptome
(Wilson et al., 2015). Specifically, the authors identified a gene
signature common to HSCs isolated from various protocols
(MolO, n = 29) and a gene signature associated with ‘‘protocol-
specific’’ HSCs (NoMo, n = 74). Strikingly, we found that
RA-CFP-dim HSCs expressed high levels of the MolO signature
genes and low levels of the NoMo signature genes (Figure 3E),
further suggesting that the RA-CFP-dim phenotype is endowed
with a superior HSC phenotype.
Next, we looked into the relative levels of some of the cell
surface markers commonly used for HSC isolation, as these
have been shown to correlate with differential HSC function.
For example, decreased levels of cKit and increased levels of
Sca1 identify a more quiescent HSC population with increased
engraftment ability (Grinenko et al., 2014; Wilson et al., 2015).
In line with the superior function of RA-CFP-dim HSCs, we found
them to express decreased and increased levels of cKit and
Sca1, respectively (Figure 3F). Moreover, increased expression
of CD150 has previously been shown to mark a more myeloid-
biased HSC population, whereas decreased levels mark a
more lymphoid-biased population (Beerman et al., 2010).Figure 3. RA-CFP-Dim HSCs Are Associated with a Distinct Gene Exp
(A) Heatmap indicating the 318 most deregulated genes between RA-CFP-dim a
N = 4.
(B) GSEA illustrating the downregulation of cell cycle genes and upregulation of
(C and D) Cell cycle analysis of RA-CFP-dim and RA-CFP-bright HSCs using eith
t test.
(E) Expression levels of MolO and NoMO signature genes.
(F) Mean fluorescence intensities (MFIs) of HSC cell surface markers as a functio
bright.
(G) GSEA of RA and RAR target genes in RA-CFP-dim and RA-CFP-bright HSCs
(H) mRNA levels (RNA-seq) of RA receptors and Gprc5c.
(I) Colony-forming potential of RA-CFP-dim and RA-CFP-bright HSCs after 3 days
into fresh M3434 and grown for an additional 4 days (2nd). Multiple comparison
depict SD. N = 4.Consistent with our transplantation data, we found that RA-
CFP-dimHSCs express relatively low levels of CD150 (Figure 3F).
Finally, and most notably, EPCR expression is markedly higher
on RA-CFP-dim HSCs versus their RA-CFP-bright counterparts
(Figure 3F).
Collectively, the gene expression data and cell surface marker
expression are consistent with the notion that RA-CFP-dim
HSCs constitute a superior HSC population within the LSK-
SLAM compartment.
RA Signaling in RA-CFP-Dim and RA-CFP-Bright
Populations
RA signaling has recently been implicated in the regulation of
HSC dormancy (Cabezas-Wallscheid et al., 2017). To test for
potential RA-regulated genes, we first assessed the expression
of a previously defined RA-target gene set (Balmer and Blomh-
off, 2002) and found no major differences between their expres-
sion in RA-CFP-dim and RA-CFP-bright HSCs (Figure 3G). As
RA-target genes may be highly cell type dependent, we also
generated RA-target gene sets on the basis of expression cor-
relations with the three individual RA receptors across the
entire ImmGEN gene expression dataset of hematopoietic cell
types (Malhotra et al., 2012; Miller et al., 2012; Narayan et al.,
2012). This analysis showed higher expression of specific
RARA and RARG target genes in RA-CFP-dim cells, despite
the similar expression levels of these receptors in our two
HSC populations (Figures 3G, 3H, and S3B). Interestingly, the
RA receptor target genes were only minimally overlapping, sug-
gesting that each RAR targets highly selective genes (Fig-
ure S3C). To assess if these expression differences also trans-
lated into functional differences, we tested the response of
RA-CFP-dim and RA-CFP-bright HSCs to RA for 3 days in cul-
ture, followed by serial replating in methyl cellulose. Consistent
with earlier findings, RA treatment led to a marked increase in
colonies following serial replating (Cabezas-Wallscheid et al.,
2017) with no differences between RA-CFP-dim and RA-CFP-
bright HSCs (Figure 3I).
These findings suggest that RA-CFP-dim HSCs are distinct
from the recently reported GPRC5C-high HSCs (Cabezas-Wall-
scheid et al., 2017), and consistently we found Gprc5c to be ex-
pressed at similar levels in RA-CFP-dim and RA-CFP-bright
HSCs (Figure 3H). Moreover, our data also demonstrate that
the expression of RA-target genes does not correlate with RA-
CFP expression in HSCs. Thus, this underlines the fact thatression Profile and Differential HSC Marker Expression
nd RA-CFP-bright HSCs (expression fold change 2, adjusted p value < 0.01).
interferon signaling in RA-CFP-dim HSCs.
er DAPI staining, n = 6 (C), or BrdU incorporation, n = 5 (D). Paired two-tailed
n of CFP expression. Paired two-tailed t test for RA-CFP-dim versus RA-CFP-
.
in liquid culture ±RA, followed by 6 days inM3434 (1st). Colonieswere replated
s were performed by one-way ANOVA within 2nd replating groups. Error bars
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Figure 4. RA-CFP-Dim HSCs Display
Higher Engraftment Levels during Serial
Transplantation
(A) Donor contribution in the peripheral blood
of mice subjected to intrafemoral injections with
100 RA-CFP-dim or RA-CFP-bright HSCs.Multiple
comparisons were performed using two-way
ANOVA. N = 6.
(B) Experimental setup for serial transplantation of
mice originally transplanted with RA-CFP-dim and
RA-CFP-bright HSCs.
(C) Donor contribution in the peripheral blood of
secondary recipients of BM isolated from mice
originally transplanted with RA-CFP-dim and RA-
CFP-bright HSCs. N = 4–7.
(D) Donor contribution to different lineages in the
mice from (C).
Error bars indicate SD.reporter genes are not necessarily capturing the entire
complexity of signaling pathways.
RA-CFP Levels Define a Population of Label-Retaining
HSCs with Increased Engraftment in Secondary
Recipients
The superior engraftment levels of RA-CFP-dim HSCs in primary
recipients could, in principle, reflect differences in homing effi-
ciency between the two HSC subpopulations. To exclude this
possibility, we directly injected RA-CFP-bright and RA-CFP-
dim HSCs into the femoral BM cavity of irradiated recipients
and compared their ability to contribute to hematopoietic regen-
eration. Similar to our findings using intravenous injections,
RA-CFP-dim HSCs also contributed more efficiently to hemato-
poietic regeneration in this setting (Figure 4A).
To more rigorously test the impact of RA-CFP levels on
HSC functional properties, we next performed a serial trans-
plantation experiment (Figure 4B). Specifically, BM cells from
recipient mice initially transplanted with 100 RA-CFP-bright
or RA-CFP-dim HSCs, along with competitor cells, were
harvested 16 weeks post-transplantation. Subsequently, 300
CD45.2+ HSCs (not fractionated on the basis of CFP levels)
were isolated and transplanted into secondary recipients.
Remarkably, mice transplanted with HSCs derived from mice
originally transplanted with RA-CFP-dim HSCs continued to
display increased donor contribution in secondary recipients
(Figure 4C). Consistent with the results from primary recipients
(Figure 2), donor contribution in these animals was skewed to-
ward the B cell lineage at the expense of the myeloid lineage
(Figure 4D).
Recently, it has been suggested that contribution of HSCs to
hematopoietic output in a transplantation setting may differ772 Cell Reports 24, 766–780, July 17, 2018from that occurring in an unper-
turbed steady-state hematopoietic sys-
tem (Busch et al., 2015; Sun et al., 2014)
We therefore wanted to address whether
RA-CFP reporter levels also affected
HSC behavior in steady state, specifically
whether RA-CFP-dim HSCs were en-riched in the fraction of so-called label-retaining cells, which
have been demonstrated to be enriched for LT-HSC activity (Wil-
son et al., 2008). We therefore crossed the Rosa26-RA-CFP
allele onto the Rosa26-rtTA::Col1a1-tetO-H2B-mCherry strain,
which allows doxycycline (dox)-induced expression of H2B-
mCherry. The resulting Rosa26-CFP/rtTA::Col1a1-tetO-H2B-
mCherry (R26-CFP/TTA; hereafter H2B-mCherry) animals were
fed for 6 weeks with dox-chow and subsequently analyzed
immediately or chased for 0, 6, 10, and 14 weeks in the absence
of dox (Figure 5A). Initial H2B-mCherry labeling efficiencies of
HSCs, LSKs, and progenitors (L-S-K+) were high, and there
were no major differences in H2B-mCherry labeling when gating
on the top 10%and bottom 10%RA-CFP-expressing HSCs (i.e.,
RA-CFP-bright and dim, respectively) (Figures 5B and 5C;
0 weeks). In contrast, RA-CFP-dim HSCs in mice chased for 6,
10, and 14 weeks displayed consistently higher levels of H2B-
mCherry, demonstrating that the RA-CFP-dim population of
HSCs are enriched in label-retaining cells (Figure 5C).
Overall, these data suggest that RA-CFP-dim HSCs constitute
an HSC population that is enriched in cells that support LT-
HSC function, both in a steady-state and in a transplantation
setting
Whole-Genome Bisulfite Sequencing of RA-CFP-Dim
and RA-CFP-Bright HSC Populations
Our data suggest that RA-CFP reporter levels can be used to
distinguish subsets of HSCs with distinct functional properties.
As differential epigenetic memory has previously been associ-
ated with distinct HSC functionality (Yu et al., 2016), we
subjected HSCs from the RA-CFP line to genome-wide DNA
methylation analysis and assembled differentially methylated
regions (DMRs) into super-DMRs (Experimental Procedures).
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Figure 5. Label-Retaining HSCs Are Enriched in the RA-CFP-Dim HSC Compartment
(A) Experimental setup.
(B) Gating strategy.
(C) Analysis of H2B-mCherry expression in progenitors (L-S-K+), LSK cells (L-S+K+), and HSCs (LSK, CD48, CD150+) following 6 weeks of labeling in the
presence of dox following a chase for the indicated times. H2B-mCherry MFI is quantified in LSKs (in order to minimize variation between experimental time-
points/mice) and HSCs (unfractionated, 10%RA-CFP dim and 10%RA-CFP bright) and normalized to the levels in LSK cells of individual mice. Error bars indicate
SD and significance was determined using a paired t test for RA-CFP-dim versus RA-CFP-bright. N = 4–8.RA-CFP-dim HSCs exhibited increased overall methylation
levels compared with RA-CFP-bright HSCs, consistent with
the general notion that HSCs are more methylated compared
with their downstream progeny (Figure S4A) (Cabezas-Wall-
scheid et al., 2014). Indeed, super-DMRs exhibited increased
methylation mainly in RA-CFP-dim HSCs. However, this was
not accompanied by systematic changes in the expression ofassociated genes (Figure S4B; Table S4). Gene Ontology anal-
ysis identified developmental genes as well as bivalent genes
(marked by H3K4me3 and H3K27me3 as being hypermethylated
in RA-CFP-dim HSCs; Figure S4C; Table S5). Overall, this anal-
ysis suggests that RA-CFP-dim and RA-CFP-bright HSCs are
associated with distinct methylation patterns but that these are
not predictive of gene expression.Cell Reports 24, 766–780, July 17, 2018 773
Single-Cell Gene Expression Reveals a Clear
Correlation between RA-CFP Levels and Cell Cycle
Status of HSCs
In order to expand on our initial transcriptome analysis on bulk
HSC populations and to gain further insights into the potential
HSC heterogeneity at the single-cell level, we performed
massively parallel RNA single-cell sequencing (MARS-seq) on
1,500 index-sorted HSCs (Jaitin et al., 2014). Clustering anal-
ysis of the 1,248 HSCs passing our quality filters revealed a total
of ten transcriptional clusters. Clusters 8–10were generally char-
acterized by higher RA-CFP reporter expression levels and were
markedly enriched for genes associated with active proliferation,
such as Pcna, Aurka, and several Mcm genes (Figure 6A).
Indeed, we found RA-CFP-dim cells to be associated mainly
with the G0/G1 phase of the cell cycle on the basis of the
scRNA-seq data (Figure 6B). Moreover, removal of cell cycle
genes from analysis also removedmost of the variance in the da-
taset (Figure 6C). Hence, cell cycle differences underlie the main
heterogeneity within the HSC compartment. The transcriptional
signatures of the remaining clusters were much weaker,
although we did observe interferon pathway genes, including
Ifitm1 and Ifitm3, to be selectively expressed in clusters 2
and 3, which are also associated with low RA-CFP reporter
expression. We also note that RA-CFP reporter expression is
highly correlated with the number of unique molecular identifiers
(UMIs) (i.e., reflecting the overall level of active transcription) and
therefore in line with the notion that RA-CFP-bright expression
marks a population of metabolically active and proliferating
HSCs (Figure S4D).
Classically, hematopoietic differentiation has been linked to
progressive lineage commitment, in which multipotency is grad-
ually lost. Recent studies using single-cell analysis, however,
suggest that oligopotent hematopoietic progenitors are speci-
fied toward a specific lineage, at least at a transcriptional level
(Paul et al., 2015; Perie´ et al., 2015). Therefore, we set out to
investigate the degree to which distinct lineage-specific gene
expression programs were expressed in HSCs. Our initial anal-
ysis did not reveal any distinct lineage-affiliated transcriptional
clusters (Figure 6A). However, we reasoned that this may be
due to the low expression of such transcripts in HSCs. To
more robustly detect potential lineage-affiliated gene expression
programs in HSCs, we compiled four gene signatures from the
literature representing HSC, myeloid, lymphoid, and erythroid/
megakaryocytic gene expression programs (Experimental Pro-
cedures). We subsequently developed a two-step approach
(Experimental Procedures) to cluster HSCs into a total of ten line-
age-associated clusters (Figures 6D and 6E). Strikingly, all po-
tential combinations of lineage-specific gene expression pro-
grams were detected, a finding that appears incompatible with
a model in which the transcriptional priming of individual HSCs
is a major determinant of hematopoietic differentiation. Impor-
tantly, we detected a similar spectrum of lineage-specific gene
expression in previously published HSC RNA-seq datasets
(Figure S4E).
We next performed a network analysis of our scRNA-seq HSC
data. In line with our initial clustering analysis, clusters 8–10 and
RA-CFP-bright cells located to the same part of the network,
further demonstrating the close association between prolifera-774 Cell Reports 24, 766–780, July 17, 2018tion and RA-CFP reporter expression (Figures 6F and 6G). In
contrast, cells expressingmyeloid, lymphoid, or erythroid/mega-
karyocytic gene signatures were scattered over the entire
network, further arguing against the notion that specific HSC
subpopulations are transcriptionally primed toward specific he-
matopoietic lineages (Figures S4F–S4H).
In a final attempt to explore the potential transcriptional het-
erogeneity within the HSC compartment, we generated diffusion
pseudotime maps of the HSC scRNA-seq data, which revealed
the presence of two distinct clusters (Figure 7A). Pathway anal-
ysis suggested that the transition from early to late pseudotime
was associated with an increase in the term Translation_Factors,
indicating that translation is more active in the late cluster (Fig-
ure 7B; Table S6). This is also supported by studies of individual
genes demonstrating that two members of the TRiC/CCT chap-
erone complex, which is involved in protein folding (Broadley and
Hartl, 2009) and likely required in cells with high protein synthesis
activity, are markedly upregulated in the late cluster (Figure 7C;
Table S7). Although the late cluster displayed a slightly elevated
cell cycle score, this did not correlate with the Translation_
Factors term, suggesting that these features are mutually inde-
pendent and that early and late cluster cells replicate to the
same extent (Figures 7B and 7D).
Taken together, our scRNA-seq data demonstrate that the
transcriptomes of individual HSCs are very homogeneous and
that themain driver of HSC heterogeneity is differences in cell cy-
cle status.
DISCUSSION
Even though current HSC isolation strategies result in high levels
of HSC purity, as measured by engraftment ability in single-cell
transplantation studies, HSC populations remain functionally
heterogeneous in terms of lineage output and long-term engraft-
ment capabilities. In this study, we investigated whether we
could use murine reporter models for cellular signaling path-
ways in order to further resolve heterogeneity within the HSC
compartment.
The RA-CFP Reporter Line Facilitates the Isolation of
Superior HSCs
By using a RA-CFP reporter line, which displays a tight and inter-
mediate level of CFP expression in HSCs, we were able to sub-
fractionate the LSK SLAM HSC compartment into functionally
distinct HSCs. Specifically, RA-CFP-dim HSCs were largely
quiescent and displayed significantly enhanced abilities of he-
matopoietic reconstitution. In contrast, RA-CFP-bright cells en-
grafted relatively poorly and were highly proliferative. Strikingly,
the superior phenotype of theRA-CFP-dimHSCswasmaintained
in secondary recipients, which suggests a limited transition be-
tween the RA-CFP-dim and RA-CFP-bright HSCs over time and
throughout challenges. This is supported not only by the DNA
methylation differences between these populations but also by
the observation that the RA-CFP-dim population is enriched in la-
bel-retaining LT-HSCs. Further characterization of the RA-CFP-
dim HSCs demonstrated that these cells were associated with
high Sca1, high EPCR, relatively lower CD150 expression, and
low cKit expression, thereby re-capitulating a previously reported
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Figure 6. ScRNA-Seq Analysis of RA-CFP HSCs
(A) Heatmap indicating the expression levels (UMIs) of the 149 most variable genes from the HSC ScRNA-seq data. The corresponding RA-CFP values
(normalized) are shown below.
(B) Individual RA-CFP-dim and RA-CFP-bright cells were assigned to the G0/G1, G2M, and S phases of the cell cycle.
(C) The contribution of the individual principal components to the variance of the data before and after removal of cell cycle genes.
(D) Lineage signature scores for single cells.
(E) Heatmap showing the expression of individual lineage signature genes. The corresponding RA-CFP and cell cycle score values are depicted below. The
hierarchical organization of the single-cell lineage clusters is also shown.
(F) SPRING-based three-dimensional (3D) network representation of the scRNA-seq data. Colors of each individual cells depict the cluster numbers from (A).
(G) Same as (D) but depicting RA-CFP expression levels (ranked for visualization purposes) in individual HSCs.
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Figure 7. Pseudotime Analysis of RA-CFP HSCs
(A) Diffusion map of individual cells color-coded as a function of pseudotime.
(B) Gene expression signature scores for early (pseudotime < 0.5) and late (pseudotime > 0.5) clusters of individual HSCs. The height represents the mean
expression score of the signature, whereas the height of the inner bar depicts the frequency of cells with a signature different from zero.
(C) Gene expression of CCT factors in individual HSC superimposed on the diffusion map.
(D) Correlation of signature gene expression in individual HSCs. The early and late pseudotime clusters are depicted separately.marker code for high-end HSCs (Wilson et al., 2015). Finally, the
transcriptome of RA-CFP-dim HSCs correlated tightly with the
MolOgeneexpression signature (i.e., genesassociatedwith func-
tional HSCs across different cell surface marker panels) (Wilson
et al., 2015). Collectively, these findings demonstrate that RA-
CFP-dim HSCs share multiple properties of high-end HSCs and
that the RA-CFP-reporter line constitutes a simple, yet efficient,
tool for their prospective isolation.
RA Signaling in the HSC Compartment
In contrast to what has been reported in the human system, RA
signaling in mice has been associated with increased HSC self-
renewal, and knockout experiments point toward the RARG iso-
form as the main RA receptor (Cabezas-Wallscheid et al., 2017;
Purton et al., 2006). The RA reporter model used in the present
study reports on the activity of a DR5 RARE, originally derived
from the Rarb promoter, which can be bound by both RXR/
RARA and RXR/RARG heterodimers (de The´ et al., 1990; Dela-
croix et al., 2010). Consequently, the reporter does not allow a
precise distinction between the actions of the different RARs.
RA signaling leads to highly tissue specific gene expression
changes. In order to correlate the behavior of the RA-CFP re-
porter with gene expression, we generated RAR-specific target
gene lists using a correlative approach. Through this approach,776 Cell Reports 24, 766–780, July 17, 2018we observed higher expression of RARA and RARG target genes
in RA-CFP-dim HSCs compared with their RA-CFP-bright coun-
terparts, suggesting that RA signaling is increased in the superior
RA-CFP-dim compartment in vivo. These findings are consistent
with previous work demonstrating RA signaling in dormant
GPRC5C+ HSCs (Cabezas-Wallscheid et al., 2017). However,
the RA-CFP-dim and GPRC5C+ HSCs are clearly not identical,
as Gprc5c expression is not increased in RA-CFP-dim HSCs.
Moreover, RA markedly promotes the serial re-plating abilities
of both RA-CFP-dim and RA-CFP-bright HSCs demonstrating
that both populations can respond efficiently to RA. These
data are consistent with a model in which RA-CFP-dim and
RA-CFP-bright HSCs are located in different anatomical posi-
tions within the BM, where they experience different levels of
RA signaling stimuli.
Collectively, we can conclude that RA-CFP levels in HSCs
correlate inversely with the expression of three distinct RA-target
gene sets. RA-CFP-dim HSCs appear to have the highest levels
of RA signaling pathway activation in vivo. Although this finding
does not detract from the fact that the RA-CFP reporter line al-
lows sub-fractionation of the HSC compartment, it obviously
raises concerns regarding the use of reporter mice reporting
on single, multimerized transcription factor binding sites as indi-
cators of pathway activity.
RA-CFP-Dim and RA-CFP-Bright HSCs Display Distinct
Gene Expression Profiles
In line with the marked functional difference in their proliferative
behavior, RA-CFP-dim HSCs were associated with a marked
reduction in the expression of cell cycle-related genes. It has
previously been reported that the proliferative status of hemato-
poietic stem and progenitor cells (HSPCs) andHSCs is important
for their engraftment ability and that the proliferating subsets of
HSPCs and HSCs display a diminished reconstitution potential
of irradiated hosts (Bowie et al., 2006; Nygren et al., 2006).
Some of these studies have suggested that this is due to the
cell cycle-specific expression of receptors important for homing
of HSCs. However, RA-CFP-dim and RA-CFP-bright HSCs do
not differ in their expression of genes encoding important recep-
tors for HSC homing, includingCxcr4,Cd44, LFA-1, or Vla4 (data
not shown), arguing against cell cycle-driven differences in hom-
ing as the underlyingmechanism. In linewith this, intrafemoral in-
jection of HSCs results in similar functional differences between
RA-CFP-dim and -bright HSCs. Moreover, the 12%–20% of
actively replicating RA-CFP-bright HSCs are unlikely to account
for the 2-fold reduction in hematopoietic engraftment observed
in this population. Instead, we favor a model in which the acti-
vated cell cycle status of the RA-CFP-bright HSCs renders
them more likely to differentiate and consequently contribute
less to hematopoietic reconstitution than their RA-CFP-dim
counterparts.
Finally, we also noted a prominent enrichment of several gene
expression signatures related to interferon signaling in RA-CFP-
dim HSCs. Although interferon-a and interferon-g are activators
of HSCs in vivo and are known to promote cell cycle entry (Bal-
dridge et al., 2010; Essers et al., 2009), several of the interferon
signature genes have previously been reported to be enriched
specifically in HSCs (Cabezas-Wallscheid et al., 2014; Wilson
et al., 2015). Moreover, several of the interferon signature genes
have been shown to be important for promoting growth arrest in
other contexts (Table S3). Consequently, these findings suggest
both that interferon signaling is associated with the exit of HSCs
from quiescence and that a certain baseline level is required for
HSCmaintenance. This in turn suggests that interferon signaling,
or at least the expression of certain interferon signaling signature
genes, must be tightly controlled in HSCs in order to prevent
HSC exhaustion.
Cell Cycle Progression Is the Main Source of
Transcriptional Heterogeneity within the HSC
Compartment
The inability to prospectively isolate an HSC population with uni-
form behavior in assays for HSC function has led to the wide-
spread notion that the HSC compartment is heterogeneous.
This view is supported by single-cell transplantation experiments
demonstrating lineage-biased behavior of HSCs as exemplified
by the myeloid-biased a-HSCs, platelet-biased Vwf+-HSCs,
and others (Dykstra et al., 2007; Sanjuan-Pla et al., 2013). How-
ever, in each case only an increase in the propensity to give rise
to a certain lineage(s) is observed, raising the possibility that the
propensity for an HSC to differentiate toward a certain lineage is
not hard wired but may instead represent stochastic changes
in gene expression. To characterize HSC heterogeneity at ahigher resolution than previously reported, we transcriptionally
profiled >1,200 HSCs using MARS-seq and found cell cycle ac-
tivity to be responsible for the main transcriptional variance
within the HSC compartment. Moreover, as the cell cycle-active
clusters are associated with high levels of RA-CFP at the single-
cell level, this finding not only supports conclusions from previ-
ous scRNA-seq studies using much lower cell numbers but
also couples cell cycle status, inferred by RA-CFP levels, to
HSC performance (Kowalczyk et al., 2015; Tsang et al., 2015).
Apart from the cell cycle-active clusters, we observed a very
limited degree of transcriptional heterogeneity within the HSC
compartment. However, when focusing on lineage-affiliated
genes, we observed a significant degree of transcriptional het-
erogeneity driven by the low expression of these genes. Strik-
ingly, we identified transcriptional clusters expressing myeloid,
lymphoid, or erythroid/megakaryocytic programs as well as
combinations thereof. However, as these clusters displayed
only limited correlation with RA-CFP levels and consequently
HSC performance, the most parsimonious explanation is that
they originate from stochastic low-level expression of lineage
programs, perhaps driven by low-abundance expression of line-
age-specific regulators. A similar model has previously been for-
warded on the basis of experiments in a multipotent cell line (Hu
et al., 1997), but in this study we address this phenomenon in the
context of >1,200 highly purified HSCs. Finally, as a natural
extension of this model it is tempting to hypothesize that the sto-
chastic sampling of lineage-affiliated transcriptional programs is
what endows individual HSCs with an increased probability to
adopt a certain fate.
In summary, we have demonstrated the utility of the RA-CFP
reporter line for sub-fractionation of the HSC compartment.
RA-CFP-dim HSCs are largely quiescent, express higher levels
of interferon-signaling genes, and are associated with superior
engraftment abilities. Single-cell transcriptome analysis demon-
strates a stochastic low-level expression of lineage-affiliated
genes, which may underlie previously reported lineage biases
of individual HSCs. However, the main functional variance within
the HSC compartment is associated with cell cycle activity. This
variance can be resolved in the RA-CFP reporter line, which we
predict will be of wide interest to the HSC community.EXPERIMENTAL PROCEDURES
Mice and Mouse Procedures
Mice were housed at the Department for Experimental Medicine at the Univer-
sity of Copenhagen according to institutional guidelines. All animal work was
approved by the Danish Animal Ethical Committee and by the review board
at the Faculty of Health Sciences, University of Copenhagen.
The generation of the -60/DR5-TA-RA-CFP, SuTOP-TA-CFP (Wnt signaling),
and IBRE4-TA-CFP (BMP signaling) mouse strains was described previously
(Serup et al., 2012).
For transplantation assays, young females (10–14 weeks, -60/DR5-TA-RA-
CFP Ly-5.2/CD45.2) were used as donors, unless otherwise stated. One
hundred donor cells were transplanted into young (10–14 weeks) congenic
(Ly-5.1/CD45.1) recipients through tail vein injection. Recipients were lethally
irradiated (900 cGy) 24 hr prior to transplantation. As support 400,000
CD45.1 wBM cells were transplanted alongside. Post-irradiation mice were
supplemented with ciprofloxacin in the drinking water (100 mg/L; Actavis or
Sigma) for 4 weeks. A blood sample was drawn from the facial vein every
4 weeks for analysis.Cell Reports 24, 766–780, July 17, 2018 777
For intrafemoral transplantations, lethally irradiated recipients (under isoflur-
ane anesthesia) received 100 RA-CFP-dim or RA-CFP-high HSCs in a volume
of 20 mL PBS in the right femur. In addition, the recipients were transplanted
with 325,000 wBM cells (intravenously [i.v.]) 5 hr prior to the procedure and
received three 0.1 mg doses of Rimadyl SC for 3 days post-transplantation.
For label-retaining experiments, we intercrossed the Rosa26-RA-CFP
allele and Rosa26-rtTA::Col1a1-tetO-H2B-mCherry (Jax mice stock number
014602) in order to generate Rosa26-CFP/rtTA::Col1a1-tetO-H2B-mCherry
experimental animals (Beard et al., 2006; Egli et al., 2007). Expression of
H2B-mCherry was induced by keeping 10- to 14-week-old females on dox-
containing food pellets (2,000 mg/kg; Ssniff Spezialdia¨ten) for 6 weeks, fol-
lowed by a chase for 0–14 weeks.
Flow Cytometry
Tibia, femur, and iliac bones were harvested from experimental animals and
crushed in PBS + 3% fetal calf serum (FCS). For the sorting of HSPC popula-
tions, BM cells were cKit enriched prior to antibody staining. Briefly, cells were
resuspended in 200 ml PBS + 3% FCS and incubated with 7 mL CD117 mag-
netic microbeads for 30 min and purified on magnetic separation columns
following the manufacturer’s protocol (Miltenyi Biotec). Prior to antibody stain-
ing of peripheral blood, 30 mL of blood was lysed twice to remove red blood
cells using Pharmlyse (BD) according to the manufacturer’s protocol. Anti-
bodies are listed in the Supplemental Information.
All flow cytometry involving analysis and sort of CFP was carried out on a
FACS AriaIII (BD) equipped with a custom 445 nm deep-blue laser. To record
the intensity of surfacemarkers used for sorting of single cells for RNA-seq, the
FACS DIVA ‘‘index sorting’’ function was activated. Blood samples were
analyzed on either an Accuri C6 (BD) or a FACSCanto (BD). Subsequent anal-
ysis was performed using FlowJo (Treestar)
In Vitro Assays
In order to assess RA-reporter response in vitro, cKit+ cells were sorted by
FACS and grown in StemSpan serum-free media (StemCell Technologies)
supplemented with 1% penicillin-streptomycin (PenStrep), 50 ng/mL murine
stem cell factor (PeproTech), and 50 ng/mL human thrombopoietin
(PeproTech). RA (ATRA) and BMS493 (both from Sigma-Aldrich) were dis-
solved in DMSO.
To assess the serial replating potential of RA-CFP-dim and RA-CFP-bright
HSCs, we plated 400 HSCs in 96 individual wells and cultured them in
100 mL StemPro-34 SFM (Life Technologies), supplemented with murine
SCF 50 ng/mL, murine TPO 25 ng/mL, 30 ng/mL human Flt3-ligand (all Pepro-
Tech), 100 U/mL PenStrep, and 2mM L-glutamine in the presence of 5 mMRA/
vehicle (DMSO). Cells were cultured for 72 hr and the contents of 96 individual
wells were transferred into M3434 semisolid medium (StemCell Technologies)
supplemented with 100 U/mL PenStrep. Colonies were counted after 6 days,
and 30,000 cells were transferred into fresh M3434 semisolid medium.
Following 4 additional days of culturing, colonies were counted.
RNA-Sequencing Analysis
ScRNA-Seq
Single HSCs were index-sorted into cold 384-well capture plates containing
2 mL of cell lysis solution and barcoded poly(T) RT primers for scRNA-seq.
cDNA frombarcoded single cells was pooled using an automated pipeline (Jai-
tin et al., 2014). The pooled sample was amplified, and the resulting RNA was
fragmented and converted into a sequencing-ready library by tagging the
samples with pool barcodes and Illumina sequences during subsequent steps
(ligation, RT, and PCR) (Jaitin et al., 2014). Libraries were sequenced on a
NextSeq500, and data were deposited in the GEO repository under accession
number GEO: GSE108155.
Each pool of cells was tested for library quality, and concentration was as-
sessed as described earlier (Jaitin et al., 2014). Cells not meeting the quality
standards were removed from the subsequent analyses; 1,248 of 1,520 sorted
cells met the quality thresholds.
Purification of RNA for Population-Based RNA-Seq
HSCs were separated into three groups depending on their CFP levels (20%
brightest, dimmest, and an intermediate group) and 400–1,000 cells were
sorted into 50 mL of LiDS lysis/binding buffer (Life Technologies). mRNA was778 Cell Reports 24, 766–780, July 17, 2018captured with 12 mL of Dynabeads oligo(dT) (Life Technologies), washed,
and eluted with 10 mL of 10 mM Tris-HCl buffer (pH 7.5). To produce gene
expression libraries, a derivation of the protocol used for generating the sin-
gle-cell expression libraries was used (Jaitin et al., 2014). Libraries were
sequenced on a NextSeq500, and data were deposited in the GEO repository
under accession number GEO: GSE108155.
Statistical Analysis
Student’s t test and one- and two-way ANOVA were used for statistical tests
(*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001).
Bioinformatics
Details regarding bioinformatic data processing are given in the Supplemental
Information.
DATA AND SOFTWARE AVAILABILITY
The accession number for the library data reported in this paper is GEO:
GSE108155.
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